T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
CSX Corp
CSX
$92.9B
| $99.3M | 0.02% |
5,200,884
+389,757
| +8% | +$9.1M |
|
|
MRTX
577
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $99M | 0.02% |
1,287,645
-97,734
| -7% | -$8.77M |
|
578
Mettler-Toledo International
MTD
$28.7B
| $98.9M | 0.02% |
143,162
-9,820
| -6% | -$7.33M |
|
|
NBIS
579
Nebius Group N.V.
NBIS
$69.3B
| $98.3M | 0.02% |
2,887,143
-580,870
| -17% | -$24M |
|
580
Banco Bradesco
BBD
$34.3B
| $98M | 0.02% |
32,135,052
+9,616,789
| +43% | +$49.5M |
|
581
Diamondback Energy
FANG
$55.9B
| $97.8M | 0.02% |
3,734,495
+1,351,509
| +57% | +$85.1M |
|
582
AGCO
AGCO
$6.96B
| $96.8M | 0.02% |
2,049,034
+255,088
| +14% | +$16.2M |
|
583
Brighthouse Financial
BHF
$3.42B
| $96.6M | 0.02% |
3,995,225
+1,473,877
| +58% | +$52.1M |
|
584
Helios Technologies
HLIO
$2.67B
| $96.4M | 0.02% |
2,541,656
+113,623
| +5% | +$4.84M |
|
585
Target
TGT
$70.6B
| $96M | 0.02% |
1,032,229
+71,535
| +7% | +$7.94M |
|
586
Agios Pharmaceuticals
AGIO
$2B
| $95.6M | 0.02% |
2,695,730
-125,905
| -4% | -$5.82M |
|
|
ATRI
587
DELISTED
Atrion Corp
ATRI
| $94.8M | 0.02% |
145,784
-608
| -0.4% | -$416K |
|
588
Archer Daniels Midland
ADM
$38.6B
| $94.5M | 0.01% |
2,684,801
-617,665
| -19% | -$25.3M |
|
589
Ally Financial
ALLY
$13.6B
| $94.4M | 0.01% |
6,541,301
-4,372,247
| -40% | -$115M |
|
590
Tractor Supply
TSCO
$18.8B
| $93.9M | 0.01% |
5,555,600
+389,585
| +8% | +$6.99M |
|
591
Fox Class A
FOXA
$27.5B
| $93.8M | 0.01% |
3,971,022
+1,241,871
| +46% | +$40.9M |
|
592
Chemed
CHE
$7.02B
| $93M | 0.01% |
214,594
+2,217
| +1% | +$990K |
|
593
Domino's
DPZ
$11.6B
| $91.8M | 0.01% |
283,390
-21,519
| -7% | -$6.64M |
|
594
Zebra Technologies
ZBRA
$18B
| $91.8M | 0.01% |
500,106
+32,403
| +7% | +$7.28M |
|
595
Adaptive Biotechnologies
ADPT
$3.89B
| $91.8M | 0.01% |
3,303,520
+1,101,522
| +50% | +$30.7M |
|
596
PTC Therapeutics
PTCT
$6.01B
| $91.6M | 0.01% |
2,052,837
-1,985,150
| -49% | -$99.9M |
|
597
Harmonic Inc
HLIT
$1.42B
| $90.9M | 0.01% |
15,775,898
+507,729
| +3% | +$3.4M |
|
598
Illumina
ILMN
$29.1B
| $90.5M | 0.01% |
340,673
-192,341
| -36% | -$53.8M |
|
599
Federal Realty Investment Trust
FRT
$10.3B
| $90.3M | 0.01% |
1,210,886
+311,156
| +35% | +$35.8M |
|
600
Moody's
MCO
$84.6B
| $90.1M | 0.01% |
426,051
+15,768
| +4% | +$3.83M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.